Showing results (111-120 of 3,452) with videos related to
Sort By:
Pageof 346
Expert Opinion on Biological Therapy|April 17, 2020
Engineering vaccinia virus as an immunotherapeutic battleship to overcome tumor heterogeneityAdrian Pelin, Stephen Boulton, Levi A Tamming, et al.Expert Opinion on Biological Therapy|May 22, 2020
Will the US$5 million onasemnogene abeparvosec treatment for spinal muscular atrophy represent 'value for money' for the NHS? A rapid inquiry into suggestions that it may be cost-effectiveMartin Connock, Lazaros Andronis, Peter Auguste, et al.Expert Opinion on Biological Therapy|May 14, 2020
One-year effectiveness, retention rate, and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a real-life multicenter studyMaria Sole Chimenti, Giulia Lavinia Fonti, Paola Conigliaro, et al.Expert Opinion on Biological Therapy|August 5, 2022
Signaling new therapeutic opportunities: cytokines in prostate cancerElias Chandran, Luke Meininger, Fatima Karzai, et al.Expert Opinion on Biological Therapy|September 20, 2021
Preclinical studies of chimeric antigen receptor-modified natural killer cells in cancer immunotherapy: a reviewMina Hosseini, Zahra Habibi, Narges Hosseini, et al.Expert Opinion on Biological Therapy|July 25, 2015
Synergy of molecular targeted approaches and immunotherapy in melanoma: preclinical basis and clinical perspectivesMartina Sanlorenzo, Igor Vujic, Adrian Moy, et al.Expert Opinion on Biological Therapy|May 29, 2015
Immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeuticsMarina A Dobrovolskaia, Scott E McNeilExpert Opinion on Biological Therapy|April 18, 2020
Cell therapy for type 1 diabetesCristian Loretelli, Emma Assi, Andy Joe Seelam, et al.Expert Opinion on Biological Therapy|April 9, 2020
Up-to-date role of biologics in the management of respiratory syncytial virusSeyhan Boyoglu-Barnum, Ralph A TrippExpert Opinion on Biological Therapy|August 18, 2021
A randomized pharmacokinetic/pharmacodynamic study comparing the bioequivalence of potential biosimilar candidate P044 with reference medicine in healthy volunteersEkaterina Raykova, Mohammad Farmahini Farahani, Stanislava Ivanova, et al.Pageof 346